The association between parathyroid hormone and mortality in dialysis patients is modified by wasting-Reference-Cited by-同舟云学术

The association between parathyroid hormone and mortality in dialysis patients is modified by wasting

Published:2009-05-27 Issue:10 Volume:24 Page:3151-3157
ISSN:1460-2385
Container-title:Nephrology Dialysis Transplantation
language:en
Short-container-title:

Author:

Drechsler Christiane,Krane Vera,Grootendorst Diana C,Ritz Eberhard,Winkler Karl,März Winfried,Dekker Friedo,Wanner Christoph

Publisher

Oxford University Press (OUP)

Subject

Transplantation,Nephrology

Link

http://academic.oup.com/ndt/article-pdf/24/10/3151/12871726/gfp260.pdf

Reference48 articles.

1. Parathyroid hormone: biosynthesis, secretion, chemistry and action;Kronenberg,1993

2. Parathyroid hormone secretion and action: evidence for discrete receptors for the carboxyl-terminal region and related biological actions of carboxyl- terminal ligands;Murray;Endocr Rev,2005

3. Coordinated control of renal Ca(2+) transport proteins by parathyroid hormone;van Abel;Kidney Int,2005

4. Increased risk of death from primary hyperparathyroidism—an update;Hedback;Eur J Clin Invest,1998

5. Clinical presentation of primary hyperparathyroidism in Europe—nationwide cohort analysis on mortality from nonmalignant causes;Nilsson;J Bone Miner Res,2002

Cited by 37 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Serum Parathyroid Hormone Predicts Mortality in Coronary Angiography Patients with Type 2 Diabetes;The Journal of Clinical Endocrinology & Metabolism;2020-08-12

2. Management of Mineral and Bone Disorders in Chronic Kidney Disease;Chronic Renal Disease;2020

3. Hemodialysis patients with low serum parathyroid hormone levels have a poorer prognosis than those with secondary hyperparathyroidism;Therapeutic Advances in Endocrinology and Metabolism;2020-01

4. Mineral and bone disorder management in hemodialysis patients: comparing PTH control practices in Japan with Europe and North America: the Dialysis Outcomes and Practice Patterns Study (DOPPS);BMC Nephrology;2018-10-05

5. Pulse versus daily oral Alfacalcidol treatment of secondary hyperparathyroidism in hemodialysis patients: a randomized controlled trial;International Journal of Nephrology and Renovascular Disease;2018-01